Literature DB >> 8755080

Experimental impeller fragmentation of iliocaval thrombosis under tulip filter protection: preliminary results.

T Schmitz-Rode1, D Vorwerk, K Schürmann, R W Günther.   

Abstract

PURPOSE: To assess the efficacy of catheter fragmentation of massive caval thrombosis and of filter protection against procedure-related pulmonary embolism.
METHODS: In 10 sheep, a self-expanding tulip-shaped filter made from Wallstent mesh (diameter 25 mm) was introduced from the right jugular approach into the proximal inferior vena cava. Experimentally induced massive iliocaval thrombosis was fragmented by an impeller catheter (expanded diameter 14 mm), which was advanced coaxially through the sheath of the expanded filter. Post-procedural cavography and pulmonary angiography were performed to document the extent of caval recanalization and pulmonary embolism.
RESULTS: In all cases, impeller fragmentation cleared the inferior vena cava and the iliac veins of thrombi completely. Fragments washed downstream were trapped in the filter. In two of the first cases, parts of the clots caused pulmonary embolism before the filter was in place. Further events were avoided by a modification of the experimental setup. Except for some small peripheral perfusion defects in two cases, pulmonary angiograms did not show any incidence of pulmonary embolism.
CONCLUSION: Our preliminary results suggest that impeller fragmentation of iliocaval thrombi under tulip filter protection is effective and does not cause significant pulmonary embolism.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8755080     DOI: 10.1007/bf02577646

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  22 in total

1.  [Fatal lung embolism during ultrahigh-dose streptokinase treatment].

Authors: 
Journal:  Dtsch Med Wochenschr       Date:  1990-11-23       Impact factor: 0.628

2.  Percutaneous embolectomy: in vitro investigations of the self-expanding tulip sheath.

Authors:  D Vorwerk; R W Guenther; C Clerc; T Schmitz-Rode; C Imbert
Journal:  Radiology       Date:  1992-02       Impact factor: 11.105

3.  Tissue plasminogen activator (rt-PA) vs heparin in deep vein thrombosis. Results of a randomized trial.

Authors:  A G Turpie; M N Levine; J Hirsh; J S Ginsberg; M Cruickshank; R Jay; M Gent
Journal:  Chest       Date:  1990-04       Impact factor: 9.410

4.  Acute inferior vena cava thrombosis. Early results of heparin therapy.

Authors:  P Girard; M P Hauuy; D Musset; G Simonneau; P Petitpretz
Journal:  Chest       Date:  1989-02       Impact factor: 9.410

5.  New device for percutaneous fragmentation of pulmonary emboli.

Authors:  T Schmitz-Rode; R W Günther
Journal:  Radiology       Date:  1991-07       Impact factor: 11.105

6.  Acute thrombosis of the inferior vena cava: treatment with saline-jet aspiration thrombectomy catheter.

Authors:  T Yamauchi; S Furui; R Katoh; T Irie; K Makita; K Takesita; S Kusano; M Katayama; A Koyama; T Saiga
Journal:  AJR Am J Roentgenol       Date:  1993-08       Impact factor: 3.959

7.  Clot-trapper device for transjugular thrombectomy from the inferior vena cava.

Authors:  E Ponomar; J E Carlson; A Kindlund; J P Rodriguez; W R Castaneda-Zuniga; D W Hunter; J W Yedlicka; K Amplatz
Journal:  Radiology       Date:  1991-04       Impact factor: 11.105

8.  Experience with the Amplatz retrievable vena cava filter.

Authors:  D H Epstein; M D Darcy; D W Hunter; C C Coleman; S M Tadavarthy; P D Murray; W R Castaneda-Zuniga; K Amplatz
Journal:  Radiology       Date:  1989-07       Impact factor: 11.105

9.  The clinical implications of acute thrombosis of the inferior vena cava.

Authors:  S P Farber; T F O'Donnell; R A Deterling; V G Millan; A D Callow
Journal:  Surg Gynecol Obstet       Date:  1984-02

10.  A strategy of aggressive regional therapy for acute iliofemoral venous thrombosis with contemporary venous thrombectomy or catheter-directed thrombolysis.

Authors:  A J Comerota; S C Aldridge; G Cohen; D S Ball; M Pliskin; J V White
Journal:  J Vasc Surg       Date:  1994-08       Impact factor: 4.268

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.